LEMBAR PERSETUJUAN SETELAH PENJELASAN (PSP)
(INFORMED CONCERN)
Sayayang bertanda tangan di bawah ini:
Nama : ………
Alamat : ………...
Telp : ………...
Umur : …………Tahun
Jenis Kelamin : Laki-laki/Perempuan
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan prosedur penelitian ini, saya secara sukarela dan tanpa paksaan menyetujui dan bersedia agar saya ikut serta dalam penelitian “Perbandingan Hasil Koreksi
Kelainan Refraksi pada Pemeriksaan Subjektif (Trial and Error) dengan Pemeriksaan Objektif (Streak Retinoskopi) tanpa Sikloplegik pada Penderita Miopia”.
Demikian suratpersetujuan bersedia ikut dalam penelitian ini saya buat untuk dapat dipergunakan seperlunya.
Medan, 2016
(………)
PEMERIKSAAN REFRAKSI
VOD : Pinhole :
VOS : Pinhole :
Hasil Koreksi dengan Pemeriksaan Subjektif (Trial and Error)
OD :
OS :
Hasil Koreksi dengan Pemeriksaan Objektif (Streak Retinoskopi)
OD :
OS :
Selisih Hasil Koreksi Pemeriksaan Subjektif dengan Pemeriksaan Objektif
OD :
Descriptives
Descriptive Statistics
64 18 55 32.25 10.940 64
Umur (tahun) Valid N (listwise)
N Minimum Maximum Mean St d. Dev iation
Jenis kel amin * BCVA (Best Correction Vi sual Acui ty) Crosstabulation
8 6 22 36
22.2% 16.7% 61.1% 100.0%
57.1% 42.9% 61.1% 56.3%
6 8 14 28
21.4% 28.6% 50.0% 100.0%
42.9% 57.1% 38.9% 43.8%
14 14 36 64
21.9% 21.9% 56.3% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% wit hin Jenis kelamin % wit hin BCVA (Best Correction Visual Acuity ) Count
% wit hin Jenis kelamin % wit hin BCVA (Best Correction Visual Acuity ) Count
% wit hin Jenis kelamin % wit hin BCVA (Best Correction Visual Acuity ) Laki-laki Subjektif & Objektif BCVA (Best Correct ion Visual Acuity )
Total minimum expected count is 6.13.
NPar Tests
Wilcoxon Signed Ranks Test
Ranks
12a 13.00 156.00
13b 13.00 169.00
39c 64 Negativ e Ranks
Positiv e Ranks Ties
Total Objekt if (Streak
Retinoskopi) : VOS (post ) - Subjektif : VOS (post)
Test Statisticsb
-.200a .841 Z
Asy mp. Sig. (2-tailed)
Objekt if
Based on negativ e ranks. a.
Wilcoxon Signed Ranks Test b.
Su bjektif * Mata Cr osstabu latio n
13 51 64
32.0 32.0 64.0
20.3% 79.7% 100.0%
20.3% 79.7% 50.0%
10.2% 39.8% 50.0%
49 11 60
30.0 30.0 60.0
81.7% 18.3% 100.0%
76.6% 17.2% 46.9%
38.3% 8.6% 46.9%
2 2 4
2.0 2.0 4.0
50.0% 50.0% 100.0%
3.1% 3.1% 3.1%
1.6% 1.6% 3.1%
64 64 128
64.0 64.0 128.0
50.0% 50.0% 100.0%
100.0% 100.0% 100.0%
50.0% 50.0% 100.0%
Count
Expected Count % wit hin Subjektif % wit hin Mata % of Total Count
Expected Count % wit hin Subjektif % wit hin Mata % of Total Count
Expected Count % wit hin Subjektif % wit hin Mata % of Total Count
Chi-Square Tests
46.629a 2 .000
50.129 2 .000
35.930 1 .000
128 minimum expected count is 2.00.
a.
Objektif * Mata Crosstab ulatio n
50 51 101
50.5 50.5 101.0
49.5% 50.5% 100.0%
78.1% 79.7% 78.9%
39.1% 39.8% 78.9%
13 12 25
12.5 12.5 25.0
52.0% 48.0% 100.0%
20.3% 18.8% 19.5%
10.2% 9.4% 19.5%
1 1 2
1.0 1.0 2.0
50.0% 50.0% 100.0%
1.6% 1.6% 1.6%
.8% .8% 1.6%
64 64 128
64.0 64.0 128.0
50.0% 50.0% 100.0%
100.0% 100.0% 100.0%
50.0% 50.0% 100.0%
Count
Expected Count % wit hin Objektif % wit hin Mata % of Total Count
Expected Count % wit hin Objektif % wit hin Mata % of Total Count
Expected Count % wit hin Objektif % wit hin Mata % of Total Count
Expected Count % wit hin Objektif % wit hin Mata minimum expected count is 1.00.
Koreksi Sub jektif terh adap Obj ektif * Mata Crosstab ulati on
16 18 34
17.0 17.0 34.0 47.1% 52.9% 100.0% 25.0% 28.1% 26.6% 12.5% 14.1% 26.6%
14 13 27
13.5 13.5 27.0 51.9% 48.1% 100.0% 21.9% 20.3% 21.1% 10.9% 10.2% 21.1%
34 33 67
33.5 33.5 67.0 50.7% 49.3% 100.0% 53.1% 51.6% 52.3% 26.6% 25.8% 52.3%
64 64 128
64.0 64.0 128.0 50.0% 50.0% 100.0% 100.0% 100.0% 100.0% 50.0% 50.0% 100.0% Count
Expected Count
% wit hin Koreksi Subjektif terhadap Objektif % wit hin Mata % of Total Count
Expected Count
% wit hin Koreksi Subjektif terhadap Objektif % wit hin Mata % of Total Count
Expected Count
% wit hin Koreksi Subjektif terhadap Objektif % wit hin Mata % of Total Count
Expected Count
% wit hin Koreksi Subjektif terhadap Objektif minimum expected count is 13.50.
Subjektif : VOD (post) * Objekti f (Streak Retinoskopi) : VOD (post) Crosstabulation
0 13 13
.0% 100.0% 100.0%
.0% 24.5% 20.3%
11 40 51
21.6% 78.4% 100.0%
100.0% 75.5% 79.7%
11 53 64
17.2% 82.8% 100.0%
100.0% 100.0% 100.0% Count
% wit hin Subjekt if : VOD (post)
% wit hin Objektif (Streak Retinoskopi) : VOD (post) Count
% wit hin Subjekt if : VOD (post)
% wit hin Objektif (Streak Retinoskopi) : VOD (post) Count
% wit hin Subjekt if : VOD (post)
% wit hin Objektif (Streak Retinoskopi) : VOD (post) Belum tepat
Tepat Subjektif : VOD (post)
Total
Belum tepat Tepat Objekt if (Streak Retinoskopi) : VOD (post)
Total
Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by -Linear
Computed only f or a 2x2 table a.
1 cells (25.0%) hav e expect ed count less than 5. The minimum expected count is 2. 23.
Subjektif : VOS (post) * Objektif (Streak Reti noskopi) : VOS (post) Crosstabulation
0 13 13
.0% 100.0% 100.0% .0% 25.0% 20.3%
12 39 51
23.5% 76.5% 100.0% 100.0% 75.0% 79.7%
12 52 64
18.8% 81.3% 100.0% 100.0% 100.0% 100.0% Count
% wit hin Subjektif : VOS (post)
% wit hin Objektif (Streak Retinoskopi) : VOS (post) Count
% wit hin Subjektif : VOS (post)
% wit hin Objektif (Streak Retinoskopi) : VOS (post) Count
% wit hin Subjektif : VOS (post)
% wit hin Objektif (Streak Retinoskopi) : VOS (post) Belum tepat
Tepat Subjektif : VOS (post)
Total
Belum tepat Tepat Objektif (St reak Retinoskopi) : VOS (post)
Total
Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by -Linear
Computed only f or a 2x2 table a.
1 cells (25.0%) hav e expect ed count less than 5. The minimum expected count is 2. 44.
Par Tests
Wilcoxon Signed Ranks Test
Ranks
11a 12.50 137.50
13b 12.50 162.50
40c 64 Negativ e Ranks
Positiv e Ranks Ties
Total Objekt if (Streak
Retinoskopi) : VOD (post) - Subjektif : VOD (post)
N Mean Rank Sum of Ranks
Objekt if (Streak Retinoskopi) : VOD (post) < Subjektif : VOD (post) a.
Objekt if (Streak Retinoskopi) : VOD (post) > Subjektif : VOD (post) b.
Objekt if (Streak Retinoskopi) : VOD (post) = Subjektif : VOD (post) c.
Test Statisticsb
-.408a
.683 Z
Asy mp. Sig. (2-tailed)
Objekt if (Streak Retinoskopi) :
VOD (post) -Subjektif : VOD (post)
Based on negativ e ranks. a.
Wilcoxon Signed Ranks Test b.
BCVA (Best Correction Visual Acuity)
14 21.9 21.9 21.9
14 21.9 21.9 43.8
36 56.3 56.3 100.0 64 100.0 100.0
BCVA dgn Subjektif BCVA dgn Objektif BCVA dgn Subjektif & Objektif
Total Valid
Frequency Percent Valid Percent
DAFTAR RIWAYAT HIDUP
I. Identitas
Nama : dr. Serly Indah Puspitasari
Tempat/Tgl Lahir : Medan /16 Juli 1986
Suku/Bangsa : Jawa/ Indonesia
Agama : Islam
Alamat : Komplek TASBI Blok. TT No. 31 Medan
II. Pendidikan
SDYayasan Pendidikan IBA Palembang, Tamat Tahun 1998 SLTPN 1Tanjung Agung Palembang, Tamat Tahun 2001 SMA IslamMalang, Tamat Tahun 2004
Fakultas Kedokteran Universitas Sumatera Utara, Tamat Tahun 2010
IV. Riwayat Pekerjaan
Dokter umum di Klinik Adisma Husada, Tahun 2010 - 2012
V. Perkumpulan Profesi
Anggota Muda Perdami Cabang Sumatera Utara Anggota Ikatan Dokter Indonesia (IDI) Sumatera Utara
Journal Reading :
1. Partial Thickness Corneal Tissue as a Patch Graft Material for Pervention of Glaucoma Drainage Device Exposure
2. One-Year Strabismus Outcomes in the Infant Aphakia Treatment Study 3. Laser-assisted In Situ Keratomileusis for Correction of Astigmatism and
Increasing Contact Lens Toleranceafter Penetrating Keratoplasty
Tulisan :
1. Meibomian Gland Dysfunction
2. Uveitis Glaucoma Hyphema Syndrome
3. Pemeriksaan Optical Coherence Tomography (OCT) pada Neuro-Oftalmologi 4. Papilloma Konjungtiva
Seminar Yang Telah Diikuti :
- Peserta Advanced Cardiac Life Support, 17-19 Desember 2010
- Peserta In One Day of Dinner Symposium of Glaucoma Today Grand Elite Hotel, 20 Februari 2013
- Peserta In The Workshop “Impact Glaucoma : Challenge That Needs To Be Incorporated” at Sumatera Eye Center Convention Hall, 23-24 Maret 2013
- Peserta Daily Practice In Pediatric Opthalmology Grand Elite Hotel, 25 Mei 2013 - Peserta Annual Scientific Meeting Trans Luxury Hotel Bandung, 7-9 Maret 2014 - Peserta Symposium Myopic Choroidal Neovascularization JW. Marriot Hotel, 24
Juni 2014
- Peserta One Day Symposium Praactical Pearls in Pediatric Ophthalmology Auditorium of Faculty of Medicine Airlangga University, 21 February 2015 - Peserta 40th Annual Scientific Meeting, 13-15 Agustus 1015
- Peserta The Sooner The Better for Glaucoma The Grand Aston City Hall, 10-12 Maret 2016
